PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10960075-0	2000	The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway.	SB 203580	29-37	mitogen-activated protein kinase 3	Homo sapiens	129-132	
10960075-6	2000	Overexpression of kinase-deficient mutants belonging to the ERK1/2, JNK, and p38 pathways showed that only dominant-negative Raf-1 abrogated SB203580-enhanced NF-kappaB activity.	SB 203580	141-149	mitogen-activated protein kinase 3	Homo sapiens	60-66	
10960075-7	2000	This would implicate the involvement of the ERK1/2 pathway in the enhancing effects of SB203580 on NF-kappaB-mediated gene transcription.	SB 203580	87-95	mitogen-activated protein kinase 3	Homo sapiens	44-50	
10960075-9	2000	SB203580 at higher concentrations activates the ERK pathway, which subsequently enhances NF-kappaB transcriptional activity.	SB 203580	0-8	mitogen-activated protein kinase 3	Homo sapiens	48-51